Stigmastanol.

Stigmastanol is the saturated stanol counterpart of sitosterol and both displace cholesterol from mixed micelles in the small intestine. Doses count together toward one plant sterol and stanol total.

Brassicasterol is another plant sterol competing for the same micellar space and NPC1L1 uptake step. Its effect on cholesterol absorption is additive with a stanol.

Plant stanols crowd the mixed micelle that also carries carotenoids across the intestinal wall, so circulating carotenoid levels fall with regular stanol intake. Raising carotenoid intake alongside is the usual answer.

Lycopene depends on the same bile salt micelle for uptake that stanols occupy. Stanol intake lowers lycopene absorption from the same meal.

Tocopherol is a fat-soluble vitamin absorbed through the same micellar route stanols compete in. Regular stanol use lowers tocopherol uptake unless intake is raised alongside.

Cholecalciferol is a sterol-family fat-soluble vitamin sharing the micellar uptake step. Heavy stanol intake at the same meal reduces how much is taken up.

Psyllium raises the viscosity of intestinal contents and carries bile acids out, while the stanol blocks cholesterol re-uptake at the micelle. The two act at different points of the same enterohepatic loop.

Oat beta-glucan binds bile acids and forces the liver to draw on cholesterol to replace them, a separate step from the stanol's block on absorption. Their effects on normal cholesterol handling are additive.

Red yeast rice monacolin acts on hepatic synthesis while a stanol acts on intestinal absorption, and absorption typically rises when synthesis is suppressed. Combining them covers both arms of the same balance.

Phospholipid emulsifiers keep crystalline stanols dispersed so they can enter the micellar phase where they compete with cholesterol. Poorly dispersed stanol passes through instead.

Plant stanols reduce the amount of cholesterol that partitions into mixed micelles, and other fat-soluble molecules that depend on the same micelles are affected alongside it. Vitamin K1 uptake is one of those. Timing the two apart, or supplying vitamin K separately, is the usual formulation response.

Carotenoids need micellar incorporation to cross the enterocyte, and stanols compete for space in those micelles. Lutein is among the carotenoids whose absorption falls when stanols are taken with a meal. Increasing carotenoid intake or separating doses is how formulators address it.

Zeaxanthin travels the same route as lutein and is affected by the same competition for micellar space. Products combining stanols with a macular carotenoid usually separate them across the day. The relationship is one of absorption, not of any opposing action in tissue.

Ubiquinone is strongly lipophilic and its uptake tracks dietary fat and micelle formation. Regular stanol intake has been associated with lower circulating levels of several lipid-carried molecules. Whether coenzyme Q10 falls enough to matter is not settled, so this row flags a plausible competition rather than a demonstrated one.

Retinyl esters are hydrolysed and taken up from mixed micelles, the same compartment stanols compete in. Reported effects on vitamin A status are smaller than those on carotenoids, since preformed vitamin A is handled somewhat differently. The competition is real at the micelle; its size differs by molecule.

Tocotrienols are absorbed through the same lipid route as tocopherols and depend on micelle formation. Plant stanols reduce that capacity. Because vitamin E travels in lipoproteins, apparent changes are usually reported after adjusting for circulating lipid levels, which is a reminder that the raw number is a marker.

Stanols only compete with cholesterol where mixed micelles form, and that requires bile plus dietary fat. Taken with a fat-free meal, a stanol dose has far less to work on. This is why stanol products are traditionally delivered in fat-containing food formats.

Bile salts are what make mixed micelles possible, and stanol activity depends on those micelles existing. Where bile output is low, the whole sterol-handling step is blunted. The pairing follows from digestive physiology; it has not been tested as a supplement combination.

Without lipolysis there are no monoglycerides and free fatty acids to assemble micelles with bile salts. Stanol competition for micellar cholesterol depends on that assembly. This is upstream digestive chemistry rather than a measured combination effect.

Free stanols are crystalline and poorly dispersible, so beverages and non-fat matrices need an emulsifier or a fine dispersion to keep them distributed. Lecithin is a standard choice. The pairing is a manufacturing matter, not a physiological one.

Viscous soluble fibre slows mixing and binds bile acids, while stanols displace cholesterol from micelles. The two operate through separate mechanisms in the same compartment, which is why they appear together in formulations. Effects reported for either are on circulating lipid markers.

Glucomannan forms a very viscous gel that increases faecal bile acid loss, obliging more hepatic bile acid synthesis from cholesterol. Stanols work earlier, at the micelle. Combining them stacks two different levers on the same lipid marker.

Long-chain omega-3 fats act mainly on hepatic triglyceride handling, while stanols act on intestinal cholesterol absorption. The mechanisms do not overlap, which is why the two are commonly formulated together. Both are described in terms of circulating lipid markers rather than outcomes.

Colonic bacteria dehydrogenate and reduce sterols and stanols to compounds such as coprostanol analogues, which changes what is excreted. Microbial composition therefore influences the fate of an unabsorbed stanol dose. This is observed microbial chemistry, not a demonstrated benefit of pairing.